NO20075943L - Anvendelse av azitromycin for fremstilling av et medikament for behandling av oyeinfeksjoner - Google Patents

Anvendelse av azitromycin for fremstilling av et medikament for behandling av oyeinfeksjoner

Info

Publication number
NO20075943L
NO20075943L NO20075943A NO20075943A NO20075943L NO 20075943 L NO20075943 L NO 20075943L NO 20075943 A NO20075943 A NO 20075943A NO 20075943 A NO20075943 A NO 20075943A NO 20075943 L NO20075943 L NO 20075943L
Authority
NO
Norway
Prior art keywords
azithromycin
medicament
treatment
manufacture
eye infections
Prior art date
Application number
NO20075943A
Other languages
English (en)
Norwegian (no)
Inventor
Jacques Luyckx
Jacques Pilotaz
Pablo Goldschmidt
Original Assignee
Thea Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=35445697&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO20075943(L) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Thea Lab filed Critical Thea Lab
Publication of NO20075943L publication Critical patent/NO20075943L/no

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/44Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0048Eye, e.g. artificial tears
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/02Ophthalmic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Ophthalmology & Optometry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Molecular Biology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
NO20075943A 2005-04-22 2007-11-19 Anvendelse av azitromycin for fremstilling av et medikament for behandling av oyeinfeksjoner NO20075943L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0504069A FR2884716B1 (fr) 2005-04-22 2005-04-22 Utilisation de l'azithromycine pour la fabrication d'un medicament destine au traitement des infections oculaires
PCT/IB2006/000963 WO2006111844A1 (fr) 2005-04-22 2006-04-21 Utilisation de l'azithromycine pour la fabrication d'un medicament de traitement des infections oculaires

Publications (1)

Publication Number Publication Date
NO20075943L true NO20075943L (no) 2008-01-15

Family

ID=35445697

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20075943A NO20075943L (no) 2005-04-22 2007-11-19 Anvendelse av azitromycin for fremstilling av et medikament for behandling av oyeinfeksjoner

Country Status (25)

Country Link
US (2) US20060252711A1 (fr)
EP (1) EP1877066A1 (fr)
JP (1) JP2008536908A (fr)
KR (1) KR20080008377A (fr)
CN (1) CN101163486B (fr)
AR (1) AR053591A1 (fr)
AU (1) AU2006238595A1 (fr)
BR (1) BRPI0608375A2 (fr)
CA (1) CA2603833A1 (fr)
EA (1) EA200702295A1 (fr)
FR (1) FR2884716B1 (fr)
HK (1) HK1119064A1 (fr)
IL (1) IL186092A (fr)
JO (1) JO3448B1 (fr)
MA (1) MA29467B1 (fr)
MX (1) MX2007013054A (fr)
MY (1) MY169533A (fr)
NO (1) NO20075943L (fr)
PE (1) PE20070157A1 (fr)
SG (1) SG164382A1 (fr)
TN (1) TNSN07370A1 (fr)
TW (1) TWI430799B (fr)
UA (1) UA94708C2 (fr)
WO (1) WO2006111844A1 (fr)
ZA (1) ZA200709872B (fr)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2098219A1 (fr) 2008-03-05 2009-09-09 PARI Pharma GmbH Compositions de macrolide ayant un goût et une stabilité améliorés
US8106111B2 (en) 2009-05-15 2012-01-31 Eastman Chemical Company Antimicrobial effect of cycloaliphatic diol antimicrobial agents in coating compositions
TWI572352B (zh) * 2012-03-01 2017-03-01 波麥堤克藥學Smt有限公司 用於製備具中鏈長度之脂肪酸的三酸甘油酯之方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100489759B1 (ko) * 1996-12-09 2005-05-16 바슈 앤드 롬 인코포레이티드 일회용 가요성 컨테이너
US6861411B1 (en) * 1997-12-02 2005-03-01 Pfizer, Inc. Method of treating eye infections with azithromycin
PT925789E (pt) * 1997-12-02 2004-10-29 Pfizer Prod Inc Es oculares utilizacao de azitromicina no tratamento topico de infecco
US7056893B2 (en) * 1999-03-31 2006-06-06 Insite Vision, Inc. Topical treatment for prevention of ocular infections
US6239113B1 (en) * 1999-03-31 2001-05-29 Insite Vision, Incorporated Topical treatment or prevention of ocular infections
FR2823441B1 (fr) * 2001-04-12 2004-09-10 Thea Lab Composition pharmaceutique a base de macrolides pour application locale en ophtalmologie et son procede de preparation

Also Published As

Publication number Publication date
IL186092A (en) 2016-05-31
KR20080008377A (ko) 2008-01-23
FR2884716B1 (fr) 2009-08-21
CN101163486B (zh) 2011-11-30
MX2007013054A (es) 2008-01-14
WO2006111844A1 (fr) 2006-10-26
MA29467B1 (fr) 2008-05-02
HK1119064A1 (en) 2009-02-27
TWI430799B (zh) 2014-03-21
SG164382A1 (en) 2010-09-29
UA94708C2 (ru) 2011-06-10
IL186092A0 (en) 2008-01-20
EA200702295A1 (ru) 2008-04-28
AR053591A1 (es) 2007-05-09
BRPI0608375A2 (pt) 2010-08-31
TW200716142A (en) 2007-05-01
PE20070157A1 (es) 2007-03-09
CA2603833A1 (fr) 2006-10-26
TNSN07370A1 (fr) 2009-03-17
JO3448B1 (ar) 2020-07-05
US20100069315A1 (en) 2010-03-18
ZA200709872B (en) 2008-09-25
FR2884716A1 (fr) 2006-10-27
CN101163486A (zh) 2008-04-16
AU2006238595A1 (en) 2006-10-26
EP1877066A1 (fr) 2008-01-16
US20060252711A1 (en) 2006-11-09
JP2008536908A (ja) 2008-09-11
MY169533A (en) 2019-04-22

Similar Documents

Publication Publication Date Title
NO20083780L (no) Topisk sammensetning omfattende en antibakteriell substans
NO20084845L (no) 2-pyrazinonderivater for behandling av sykdom eller tilstander der inhibiering av neutrofil elastaseaktivitetet er gunstig
BRPI1007379B8 (pt) composições farmacêuticas para o tratamento ou prevenção de infecções orais por e. coli
EA200870019A1 (ru) Лактамовые соединения и способы их применения
DE602007006815D1 (de) 4-ä5-methoxy-6-(2-methyl-6-ä1,2,4ütriazol-1-yl-pyridin-3-ylamino)-pyrimidin-4-yloxyü-piperidin-1-carbonsäure isopropyl ester als stoffwechselmodulatore und behandlung von damit assoziierten erkrankungen
NO20064186L (no) Substituerte pyrazolin sammensetninger for a redusere triglycerider i blod
DE602007013391D1 (de) Cyclosporins zur behandlung und vorbeugung von augenerkrankungen
MY169564A (en) Substituted dihydropyrazolones and their use
EA200802223A1 (ru) 1,5-дифенилпиразолы ii в качестве ингибиторов hsp90
NO20081942L (no) Karbamoylbenzotriazolderivater som inhibitorer av lipaser og fosfolipaser
ECSP055844A (es) Nuevos compuestos triciclicos
WO2007075695A3 (fr) Utilisation de derives de sulfamide heterocyclique benzo-fusionne pour le traitement de la manie et du trouble bipolaire
WO2009109654A8 (fr) Nouveaux dérivés de 1-benzyl-3-hydroxyméthylindazole et leur utilisation dans le traitement des maladies basées sur l’expression de mcp-1 et cx3cr1
RU2012103458A (ru) Композиции, включающие финафлоксации, и способы лечения офтальмологических, ушных или назальных инфекций
MXPA06012206A (es) Composicion farmaceutica ozonizada y metodos.
WO2006108681A3 (fr) Substances et compositions pharmaceutiques pour l'inhibition de glyoxalases et leur utilisation contre des bacteries
NO20092655L (no) 2-kinolinon- og 2-kinoksalinonderivater og deres anvendelse som antibakterielle midler
NO20075943L (no) Anvendelse av azitromycin for fremstilling av et medikament for behandling av oyeinfeksjoner
ATE410443T1 (de) Heterocyclyl-substituierte nonadepsipeptide
WO2007095609A3 (fr) Utilisation de dérivés de benzo-hétéroaryl sulfamide pour le traitement d'une manie et de trouble bipolaire
BR0313589A (pt) Uso de extrato de germe de trigo fermentado como agente antiinflamatório
WO2007095611A3 (fr) Utilisation des derives de benzo-heteroaryl sulfamide dans le traitement de la migraine
ATE496047T1 (de) Phenylen-bis-oxazolidin-derivate und ihre verwendung als antikoagulantien
BRPI0602179A (pt) composição farmacêutica compreendendo ciclobenzaprina e aceclofenaco em combinação
WO2006076119A3 (fr) Traitement de dermatoses

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application